HepaLife(TM) Releases Positive New Research Results for First-of-Its-Kind Bioartificial Liver Sep 26 2007, 9:15 AM EDT
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010 Aug 13 2007, 9:15 AM EDT
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device Jul 9 2007, 9:15 AM EDT
HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference Jun 25 2007, 9:15 AM EDT
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting May 29 2007, 9:15 AM EDT
HepaLife Expands Management Team on Heels of Favorable Outcomes of First-of-Its-Kind Bioartificial Liver Device May 8 2007, 9:15 AM EDT
HepaLife's Cells for Artificial Liver Device Significantly Outperform Most-Widely Used Human Liver Cell Line Apr 10 2007, 9:15 AM EDT